Targeting interleukin-33 in rheumatoid arthritis.
Chao
C
Rong
Wei
W
Hu
Fan-Rong
FR
Wu
Fei-Hu
FH
Chen
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D005347:Fibroblasts / Q000276:immunology*; D006801:Humans; D018836:Inflammation Mediators / Q000378:metabolism*; D053583:Interleukin-1beta / Q000378:metabolism*; D007378:Interleukins / Q000378:metabolism*; D008297:Male; D013582:Synovial Fluid / Q000276:immunology*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D018501:Antirheumatic Agents; D018836:Inflammation Mediators; D053583:Interleukin-1beta; D007378:Interleukins; D014409:Tumor Necrosis Factor-alpha